Healthcare

The companies featured on PressReleaseFinder are active in several industries.


Purity with purpose: Clariant Health Care raises the bar for pharmaceutical excipients

Explore Clariant’s full excipient portfolio firsthand at CPhI Milan. © ClariantExcipients are the backbone of every drug formulation. Though often described as "inactive" ingredients, they determine how an active substance dissolves, stabilizes, and ultimately reaches the patient. As formulation complexity grows and regulatory scrutiny intensifies, the industry has moved well beyond asking whether an excipient meets specification. Formulators and quality assurance teams now demand clarity on impurity profiles, endotoxin levels, elemental impurities, nitrosamine risk, and batch-to-batch consistency.

Why excipients are the unsung heroes of modern medicine

Clariant’s high-purity pharmaceutical excipients were recently highlighted at the Clariant Health Care Seminar in Jakarta, Indonesia.
© Clariant 
They don't treat disease. They rarely get a mention on a medicine label. Yet without them, most modern therapeutics simply wouldn't work. Pharmaceutical excipients – the ingredients that help an active drug substance dissolve, stabilize, and reach patients safely – sit quietly behind nearly every tablet, injectable, and topical treatment on the market.

Clariant expands pharmaceutical-grade PEG manufacturing into North America with Texas facility

Excipient GMP-compliant manufacturing site in Clear Lake, Texas strengthens regional supply chain. 
© ClariantClariant is expanding its Clear Lake site to include excipient GMP-compliant manufacturing of pharmaceutical-grade polyethylene glycol (PEG) excipients, significantly improving their availability and reliability for North American customers, with extended reach to Latin America. The multi-phase expansion addresses critical industry priorities around supply-chain security, continuity, and responsiveness while demonstrating Clariant's long-term strategic commitment to the U.S. pharmaceutical market.

At MD&M West SABIC debuts biocompatible materials and fluoropolymer alternatives, and demonstrates rapid application development

Molded from LNP™ ELCRES™ SLX resin, Rotaid’s AED cabinet cover provides impact and UV protection. 
(Rotaid)SABIC, a global leader in the chemical industry, is showcasing at MD&M West 2026 medical-grade thermoplastics that help address performance, regulatory and production challenges. The company is exhibiting at Booth #3251 specialty materials well-suited for use in drug delivery, patient testing and surgery. SABIC is unveiling a new family of polycarbonate (PC) copolymers certified under UL746G, and new biocompatible SILTEM HU resins, which can potentially replace fluoropolymers in medical tubing. It is also illustrating its multi-prong approach to helping global customers accelerate application development through plastic design, prototyping, testing and processing services.

SABIC’s new UL746G-certified LNP ELCRES NPCRX resin can help medical device makers comply with upcoming PFAS regulations

SABIC’s new LNP™ ELCRES™ NPCRX9612U resin, the first grade in a family of polycarbonate copolymer resins formulated without fluorine or other per- and polyfluoroalkyl substances (PFAS), is well suited for applications such as insulin pumps, diagnostic imaging devices and monitors.SABIC, a global leader in the chemical industry, has introduced LNP™ ELCRES™ NPCRX9612U resin, the first grade in a family of polycarbonate copolymer resins formulated without fluorine or other per- and polyfluoroalkyl substances (PFAS). In addition to being certified under UL746G, an outline of investigation for non-fluorine and non-PFAS containing materials, the new resin delivers excellent chemical resistance to withstand harsh healthcare disinfectants, and provides UL94 V0 flame retardance at 1.5mm for thin-wall geometries. The growing NP resin portfolio, whose grade prefix indicates a UL746G-certified resin, can help manufacturers across multiple industries anticipate and adapt to increasingly stringent regulatory requirements and performance demands.

Syensqo PEEK polymer enables lightweight and precise orthopedic surgical guide through Brazilian partnership

Syensqo PEEK polymer enables lightweight and precise orthopedic surgical guide through Brazilian partnership. (Photo: Syensqo, PR098)Syensqo’s high-performance, medical-grade KetaSpire® PEEK has enabled the development of a new generation of orthopedic surgical guides made from the advanced polymer. Through a collaboration between Hanisch Medical and TechImport, two leading Brazilian health technology companies, these new guides provide surgeons with a lighter and more radiotransparent alternative to traditional metal instruments.